Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | BLTE Belite Bio Inc | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $168.67 -1.3% | $15.58 +3.5% |
| StockIQ Score | 66B- Moderate Risk: Medium | 37F Weak Risk: Medium |
| Technical | 64C+ | 16F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 80A- | 50C- |
| Quality | — | 50C- |
| Risk | 50C- | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
BLTE scores much higher on investor confidence (79) and technical analysis (85) than AAPG (35 and 13). Conversely, AAPG provides available fundamental (35), growth (50), and valuation (38) scores, whereas those for BLTE are not provided. Thus, BLTE appears stronger in investor and technical metrics, while AAPG offers more insight in fundamentals, growth, and valuation.